The Dna Vaccines market size is valued at USD 576.1 Mn in 2026.
The Dna Vaccines market is projected to grow at a CAGR of 7% by 2033.
The Dna Vaccines market growth is driven by the rising prevalence of cancer and infectious diseases, increasing investments in vaccine R&D, and growing demand for veterinary vaccines.
North America is the dominating region for the Dna Vaccines market.
Inovio Pharmaceuticals, Zoetis Inc., Zydus Cadila, GeneOne Life Science, and GeoVax Labs, Inc. are some leading industry players in the Dna Vaccines market.